Class Action AMAG Pharmaceuticals

Security Name: AMAG Pharmaceuticals, Inc

Case Name: Silverstrand Investments, et. al. v. AMAG Pharmaceuticals, Inc., et. al.

CUSIP: 00163U106

ISIN: US00163U1060

Claim Filing Deadline: December 30, 2014

Exclusion Deadline: January 9, 2015

Qualification criteria: 

Investors who purchased or acquired AMAG Pharmaceuticals, Inc. (“AMAG” or the “Company”) common stock pursuant and/or traceable to AMAG’s Registration Statement filed with the SEC, No. 333-164400, dated January 19, 2010 and the accompanying Prospectus dated January 21, 2010 issued in connection with the secondary offering conducted on or about January 21, 2010 (the “Offering”) and are not otherwise excluded from the Settlement Class (see Question 6 below), could get a payment from a class action settlement. 

Class Action Settlement Website: http://www.amagsecuritiessettlement.com/

Class Action Notice HERE

Proof of Claim and Release HERE